期刊文献+

颈动脉狭窄的病因、病理学和内科治疗 被引量:6

Etiology, Pathology and Medical Treatment of Carotid Artery Stenosis
原文传递
导出
摘要 颈动脉狭窄是缺血性卒中的主要病因之一。最近的研究发现,高同型半胱氨酸血症和基质金属蛋白酶及其内源性组织抑制剂在颈动脉狭窄中起重要作用。针对这2种新型危险因素的干预措施在将来缺血性脑血管病的防治中可能有广阔的应用前景。 Carotid artery stenosis is one of the major causes of ischemic stroke. Recent studies have found that homocysteinemia and matrix metalloproteinase and its endogenous tissue inhibitor play important roles in carotid artery stenosis. The interventional strategies that aim at the 2 new risk factors may have extensive prospects of application in the future prevention and treatment of ischemic cerebrovascular disease.
作者 樊东升
出处 《国际脑血管病杂志》 2006年第9期717-720,共4页 International Journal of Cerebrovascular Diseases
关键词 颈动脉狭窄 高同型半胱氨酸血症 基质金属蛋白酶 缺血性卒中 carotid artery stenosis homocysteinemia matrix metalloproteinase ischemic stroke
  • 相关文献

参考文献12

  • 1樊东升,李小英,张捷,杨志杰,谢汝萍.中国脑卒中患者血清同型半胱氨酸水平的研究[J].中华内科杂志,2001,40(5):309-309. 被引量:34
  • 2Li Z, Sun L, Zhang H, et al.Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke, 2003,34:2085 -2090. 被引量:1
  • 3Sacco RL, Anand K, Lee HS, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study.Stroke, 2004, 35 : 2263 - 2269. 被引量:1
  • 4Pnievcsld J, Chodakowska-Zebrowska M, Wozniak R, et al. Plasma homocysteine level and the course of ischemic stroke. Acta Neurobiol Exp (Wars), 2003, 63:127 - 130. 被引量:1
  • 5Spencer CG, Martin SC, Felmeden DC, et al. Relationship of homocysteine to markers of platelet and endothelial activation in 'high risk" hypertensives: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int J Cardiol, 2004, 94:293 -300. 被引量:1
  • 6Wang H, Fan D, Zhang H, et al. Serum level of homocysteine is correlated to carotid artery atherosclerosis in Chinese with ischemic stroke.Neurol Res, 2006, 28 : 25 - 30. 被引量:1
  • 7A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.Lancet, 1996, 348:1329 - 1339. 被引量:1
  • 8Zhao SP, Liu L, Cheng YC, et al. Xuezhikang, an extract of cholestin,protects endothelial function through antiinflarnmatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation,2004, 110:915 - 920. 被引量:1
  • 9Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA, 2004, 291:565-575. 被引量:1
  • 10Ikeda U, Shimpo M, Ohki R, et al. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells. Hypertension, 2000, 36:325 -329. 被引量:1

二级参考文献1

共引文献33

同被引文献61

引证文献6

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部